Alkhazrajy W, Khorasanee A D, Russell W J
Department of Anaesthesia and Intensive Care, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia.
Anaesth Intensive Care. 2004 Apr;32(2):256-9. doi: 10.1177/0310057X0403200216.
Residual muscle weakness after general anaesthesia, assessed using handgrip strength, was audited in a teaching hospital. The relationships between residual weakness, the use of muscle relaxants and patient characteristics were examined. Handgrip strength was measured preoperatively, one hour postoperatively and one day postoperatively using a hand dynamometer in 151 patients having general anaesthesia. Forty-nine patients received no muscle relaxant, 34 patients received vecuronium and 68 received rocuronium. Patients were managed by their anaesthetist according to that anaesthetist's clinical choice. All patients who received muscle relaxants received neostigmine. One hour postoperatively, there was a decline in handgrip strength of 16% for the no relaxant group, 24% for vecuronium and 29% for rocuronium. The degree of weakness for the relaxant groups was unrelated to age (P=0.89) but was strongly influenced by the patient's sex. Almost all of the increased weakness with relaxants was found in the female patients. The mean decline in handgrip strength in the male patients who received either vecuronium or rocuronium was similar to that seen when relaxants had not been used (P=0.40). One hour postoperatively, female patients showed a marked decrease in handgrip strength after both vecuronium and rocuronium (32% and 34% respectively, combined P=0.01). These results suggest that in usual clinical practice at our institution, female patients are more likely to have residual weakness after muscle relaxants.
在一家教学医院对全身麻醉后使用握力评估的残余肌肉无力情况进行了审核。研究了残余无力、肌肉松弛剂的使用与患者特征之间的关系。在151例接受全身麻醉的患者中,术前、术后1小时和术后1天使用握力计测量握力。49例患者未接受肌肉松弛剂,34例患者接受维库溴铵,68例患者接受罗库溴铵。患者由麻醉医生根据其临床选择进行管理。所有接受肌肉松弛剂的患者均接受新斯的明治疗。术后1小时,未使用松弛剂组的握力下降了16%,维库溴铵组下降了24%,罗库溴铵组下降了29%。松弛剂组的无力程度与年龄无关(P=0.89),但受患者性别的强烈影响。几乎所有因使用松弛剂而增加的无力情况都出现在女性患者中。接受维库溴铵或罗库溴铵的男性患者握力的平均下降与未使用松弛剂时相似(P=0.40)。术后1小时,女性患者在使用维库溴铵和罗库溴铵后握力均显著下降(分别为32%和34%,合并P=0.01)。这些结果表明,在我们机构的常规临床实践中,女性患者在使用肌肉松弛剂后更有可能出现残余无力。